Our study suggests that despite deficiencies in either MTO1 or GTPBP3 cause hypertrophic cardiomyopathy with lactic acidosis, the underlying metabolic signalling in patient cells may be different (see Supplementary Discussion). This evidence concerns the gene GTPBP3 and lactic acidosis.